| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 1344.4 | 1179.5 | 960.7 |
| Other income | 18.6 | 16.4 | 4.2 |
| Total income | 1363.0 | 1195.9 | 964.9 |
| Profit before exceptional items & tax | 92.3 | 56.6 | 97.1 |
| Exceptional items | 13.2 | 0.0 | -0.3 |
| Profit before tax | 105.5 | 56.6 | 96.8 |
| Net profit | 74.6 | 37.4 | 72.0 |
| Operating margin | 7.7% | 4.7% | 10.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +3.60% |
|---|---|
| Net profit, quarter on quarter | +99.50% |
| Revenue, year on year | +39.90% |
| Operating profit, year on year | -20.70% |
| Operating profit, quarter on quarter | +83.30% |
NSE results filing, NSE: KIMS. Figures extracted from the filing.
Krishna Institute of Medical Sciences Ltd: key numbers
- Share price
- ₹745.35
- Market cap
- ₹31,305 Cr
- Revenue (annual)
- ₹3,905 Cr
- Net profit (annual)
- ₹241.4 Cr
- P/E (TTM)
- 153.2×Sector 53.8×
- Promoter holding
- 32.66%+0.16% QoQ
- FII holding
- 15.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Krishna Institute of Medical Sciences Ltd
All →Krishna Institute of Medical Sciences Management Change
KIMS re-appointed Dr. Abhinay Bollineni as Director & CEO, Dr. Bhaskara Rao Bollineni as CMD, and Ms. Dandamudi Anitha as Whole-time Director. Terms start in 2027.
- Execution
- 5 years
Krishna Institute of Medical Sciences Investor Presentation: Key Takeaways
Q2 FY27 total revenue Rs13,630 Mn (+41.3% YoY), EBITDA Rs2,789 Mn (20.5% margin), PAT Rs757 Mn (+5.1% YoY). Expansion via 700+ beds planned.
Krishna Institute of Medical Sciences Results Update
KIMS reported Q2 FY27 consolidated revenue of Rs 1,363 Crore, up 41.3% YoY, with PAT of Rs 76 Crore. EBITDA rose 34% YoY to Rs 279 Crore.
Krishna Institute of Medical Sciences Capacity Expansion
KIMS Saveera Hospital in Anantapur expanded from 250 to 500 beds, with new oncology and mother-and-child blocks inaugurated November 1, 2026. No monetary value disclosed.
- hospital beds
- 250.0 beds
Krishna Institute of Medical Sciences Acquisition Worth ₹15 Cr
KIMS acquired a 5.82% stake in Ushahkal Abhinav Specialty Hospital LLP for Rs.15 Crore via primary infusion. The Sangli hospital reported FY26 turnover of Rs.80.42 Crore.
- Value
- ₹15.00 Cr
Krishna Institute of Medical Sciences Acquisition Worth ₹79.5 Cr
KIMS Ltd acquired a 51% stake in Sarvottam Health Care Private Limited for up to ₹79.50 Crore, aiming to expand its healthcare operations in Kakinada.
- Value
- ₹79.50 Cr